Abstract:Cancer progression is an intricate biological process profiled by not only unscheduled proliferation, but also altered metabolism mechanisms. In this article, we introduced a novel tumor suppressor gene (TSG), Zinc Finger DHHC-Type Containing 1 (ZDHHC1, also known as ZNF377), frequently silenced due to epigenetic modification among various cancers, which exerts significant anti-tumor effects through metabolic regulation.Methods: Quantitative reversed-transcription PCR (qRT-PCR), reverse transcription PCR (RT-PCR) and Western blot were employed to demonstrate transcriptional and protein levels of targeted regulators. Methylation of ZDHHC1 promoter was detected by bisulfite genomic sequencing (BGS) and methylation specific PCR (MSP). Proteomics were analyzed by isobaric tags for relative and absolute quantitation (iTRAQ) and gas chromatography-mass spectrometry (GC-MS) were utilized for metabolomics analysis. Cellular functions were examined via corresponding approaches. Nude mice were used for xenograft tumor models. Indirect immunofluorescence staining was utilized to obtain precise location and expression of target proteins. Oxidative and ER stress indicators were detected using specific kits.Results: We found that ZDHHC1 expression was frequently silenced in multiple tumor cells and specimens due to methylation. Restoration of ZDHHC1 expression can curb cancer cell progression via stimulating apoptosis and cell cycle arrest, repressing metastasis, and reversing EMT transition and cell stemness. ZDHHC1's salient anti-tumor abilities were recognized in vivo as well. Metabolomic and proteomic analyses predicted inhibitory role of ZDHHC1 in glucose metabolism pathways in a CYGB-dependent manner, and in pentose phosphate pathway (PPP), which was validated by examining altered key factors. Moreover, we unraveled that ZDHHC1 dedicates to the increment of oxidative stress and endoplasmic reticulum (ER) stress to promote pyroptosis for anticancer purposes.Conclusion: Our study for the first time indicates ZDHHC1 is a potential tumor-suppressor frequently silenced due to promoter methylation, capable of negatively regulating metabolisms of tumor cells while stimulating oxidative stress and ER stress to expedite cell death through induction of pyroptosis and apoptosis, which can be exploited for development of new cancer prevention and therapies.

Methylenetetrahydrofolate Dehydrogenase 1 Silencing Expedites the Apoptosis of Non-Small Cell Lung Cancer Cells Via Modulating DNA Methylation

Regulation of Dna Methylation on the Expression of the Fhit Gene Contributes to Cervical Carcinoma Cell Tumorigenesis

MTHFD2 Promotes Tumorigenesis and Metastasis in Lung Adenocarcinoma by Regulating AKT/GSK‐3β/β‐catenin Signalling

The Loss-of-function of DNA Methyltransferase 1 by Sirna Impairs the Growth of Non-Small Cell Lung Cancer with Alleviated Side Effects Via Reactivation of RASSF1A and APC in Vitro and Vivo.

Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells

Down‐regulation of MTHFD2 Inhibits NSCLC Progression by Suppressing Cycle‐related Genes

Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

Epigenetic silencing of TET1 mediated hydroxymethylation of base excision repair pathway during lung carcinogenesis

Pharmacological Targeting of MTHFD2 Suppresses NSCLC Via the Regulation of ILK Signaling Pathway

RNA Interference-Mediated Knockdown of DNA Methyltransferase 1 Leads to Promoter Demethylation and Gene Re-Expression in Human Lung and Breast Cancer Cells

DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis

Knockdown of Dna Methyltransferase-1 Inhibits Proliferation and Derepresses Tumor Suppressor Genes in Myeloma Cells

CHFR Methylation Strongly Correlates with Methylation of DNA Damage Repair and Apoptotic Pathway Genes in Non-Small Cell Lung Cancer.

Inhibition of DNA Methyltransferase 1 by RNA Interference Reverses Epithelial-Mesenchymal Transition in Highly Metastatic 95D Lung Cancer Cells by Inhibiting the Wnt Signaling Pathway

DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721

Significance of Methylation of FBP1 Gene in Non-Small Cell Lung Cancer

DNA Methylation-Regulated HK1 Overexpression Contributes to Irradiation-Resistance by Promoting Glycolysis in Non-Small Cell Lung Cancer

Biological and Clinical Significance of Epigenetic Silencing of MARVELD1 Gene in Lung Cancer

KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer

Methylation of Promoter for Hmlh1 in Non-small Cell Lung Cancer